MET1A Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Biological Context of MET-Targeting Antibodies

MET1A antibody refers to therapeutic or research-grade monoclonal antibodies targeting the MET receptor tyrosine kinase, a proto-oncogene critical for cancer progression. While the term "MET1A" is not standardized in literature, it likely denotes antibodies against MET (mesenchymal-epithelial transition factor), a high-affinity receptor for hepatocyte growth factor (HGF). MET drives invasive growth, metastasis, and therapeutic resistance in cancers like non-small-cell lung cancer (NSCLC) .

Mechanisms of Action

Anti-MET antibodies disrupt MET signaling through:

  • Ligand blockade: Preventing HGF binding to MET’s extracellular domain .

  • Receptor internalization: Inducing MET clustering and degradation (e.g., ARGX-111) .

  • Bispecific targeting: Dual engagement of MET and other receptors (e.g., EGFR/MET bispecific antibody amivantamab) .

  • Antibody-drug conjugates (ADCs): Delivering cytotoxic payloads to MET-overexpressing cells (e.g., telisotuzumab vedotin) .

Key Anti-MET Antibodies in Clinical Development

Antibody NameTypeTargetClinical PhaseKey Findings
AmivantamabBispecific (EGFR/MET)EGFR exon 20, METApprovedORR: 40% in EGFR exon 20 NSCLC; extends efficacy post-osimertinib resistance .
Telisotuzumab VedotinADC (MET)METPhase IIIORR: 30% in MET-overexpressing NSCLC; tolerable safety profile .
ABBV-400ADC (c-MET)c-METPhase IORR: >30% in high c-MET tumors; manageable hematologic toxicity .
REGN5093-M114Bispecific (MET)METPreclinicalEnhances NK cell-mediated cytotoxicity in MET-driven cancers .

Efficacy in NSCLC

  • Amivantamab demonstrated a 44% objective response rate (ORR) in HER2-mutant NSCLC, with median progression-free survival (mPFS) of 6 months .

  • ABBV-400 showed a 15% ORR in low c-MET tumors and 30% in high c-MET tumors at doses ≥2.4 mg/kg .

Resistance Mechanisms and Biomarkers

  • MET amplification: Observed in 5–20% of EGFR-mutant NSCLC post-TKI therapy .

  • Dysregulated downstream pathways: Activation of RAS-MAPK or PI3K-AKT despite MET inhibition .

  • Biomarkers: MET overexpression (IHC), MET exon 14 skipping mutations, and MET amplification predict response .

Research Applications and Preclinical Insights

  • MET clustering: Anti-MET antibodies induce polarized receptor clusters on the plasma membrane, accelerating internalization and degradation .

  • MAT1A interaction: Methionine adenosyltransferase 1A (MAT1A) overexpression correlates with chemoresistance in bladder cancer, though unrelated to MET signaling .

Future Directions

  • Combination therapies: Pairing MET antibodies with TKIs or immune checkpoint inhibitors to overcome resistance .

  • Novel ADCs: Optimizing payloads (e.g., topoisomerase inhibitors) to enhance tumor specificity .

  • Biomarker refinement: Developing liquid biopsies for real-time MET amplification monitoring .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
MET1A antibody; MET1-1 antibody; Os03g0798300 antibody; LOC_Os03g58400 antibody; OsJ_12965 antibody; OSJNBa0094F01.4DNA antibody; cytosine-5)-methyltransferase 1A antibody; OsMET1a antibody; EC 2.1.1.37 antibody; DNA methyltransferase 1-1 antibody; OsMET1-1 antibody
Target Names
MET1A
Uniprot No.

Target Background

Function
MET1A Antibody is likely involved in the methylation of CpG residues, contributing to the maintenance of DNA methylation. This process may be associated with methylation-dependent gene silencing. While MET1A antibody plays a role in DNA methylation maintenance, its contribution may be considered minor.
Database Links
Protein Families
Class I-like SAM-binding methyltransferase superfamily, C5-methyltransferase family
Subcellular Location
Nucleus.
Tissue Specificity
Expressed in roots and inflorescences. Expressed in roots, panicles, anthers, pistils, endosperm and imbibed embryos. Expressed in tissues containing actively replicating and dividing cells, such as shoot and root meristems.

Q&A

What is MET1A and what is its biological significance?

MET1A is a DNA methyltransferase protein found in Oryza sativa subsp. japonica (Rice) and other plant species. It plays a crucial role in maintaining CpG methylation patterns during DNA replication. The protein is encoded by the LOC4334435 gene in rice and functions primarily in epigenetic regulation processes . Unlike the mammalian protein MATα1 (Methionine adenosyltransferase α1), which is involved in S-adenosylmethionine biosynthesis , plant MET1A is specifically involved in DNA methylation maintenance.

The biological significance of MET1A lies in its essential role in maintaining genomic stability, regulating gene expression, and protecting the genome from transposable elements. Research has shown that alterations in MET1A expression can lead to significant changes in methylation patterns, potentially affecting plant development and stress responses.

What are the key applications of MET1A antibody in plant research?

MET1A antibody has several important applications in plant research:

  • Western Blotting (WB): For detecting and quantifying MET1A protein levels in plant tissue extracts

  • Enzyme-Linked Immunosorbent Assay (ELISA): For sensitive quantification of MET1A in complex biological samples

  • Chromatin Immunoprecipitation (ChIP): For identifying genomic regions associated with MET1A binding

  • Immunohistochemistry: For visualizing the cellular and subcellular localization of MET1A in plant tissues

  • Protein interaction studies: For investigating protein complexes involving MET1A

These applications enable researchers to study MET1A's role in various biological processes, including developmental transitions, environmental responses, and epigenetic regulation mechanisms.

How do I select the appropriate MET1A antibody for my research?

When selecting a MET1A antibody, consider the following factors:

  • Antibody type: Polyclonal antibodies like the one described in the search results offer good sensitivity but may have batch-to-batch variation. Monoclonal antibodies provide higher specificity and consistency .

  • Species reactivity: Ensure the antibody recognizes MET1A from your species of interest. The antibody discussed is specific for rice MET1A .

  • Applications: Verify that the antibody has been validated for your intended application (WB, ELISA, etc.) .

  • Immunogen information: Understanding the immunogen used to generate the antibody helps predict epitope recognition. The antibody described uses recombinant Oryza sativa MET1A protein as the immunogen .

  • Validation data: Request validation data showing the antibody's specificity and sensitivity in applications similar to your planned experiments.

What are the optimal conditions for Western blot analysis using MET1A antibody?

For optimal Western blot results with MET1A antibody, follow these guidelines:

  • Sample preparation:

    • Extract proteins using a buffer containing protease inhibitors

    • Heat samples at 95°C for 5 minutes in reducing SDS buffer

    • Load 20-50 μg of total protein per lane

  • Electrophoresis and transfer:

    • Use 8-10% SDS-PAGE gels (MET1A is a large protein)

    • Transfer to PVDF membrane at 25V overnight at 4°C

  • Blocking and antibody incubation:

    • Block with 5% non-fat milk in TBST for 1 hour at room temperature

    • Incubate with MET1A antibody (recommended dilution as per manufacturer's instructions)

    • Use the recombinant immunogen protein provided with the antibody as a positive control

    • Include pre-immune serum as a negative control

  • Detection:

    • Use HRP-conjugated secondary antibody specific to rabbit IgG

    • Develop using enhanced chemiluminescence (ECL) substrate

  • Controls:

    • Always include the provided recombinant immunogen protein as a positive control

    • Use the pre-immune serum to identify non-specific binding

How can I optimize ELISA protocols using MET1A antibody?

For optimal ELISA results with MET1A antibody:

  • Coating parameters:

    • Use carbonate/bicarbonate buffer (pH 9.6) for coating

    • Coat plates with 1-10 μg/ml of capture antibody or antigen

    • Incubate overnight at 4°C

  • Blocking:

    • Block with 1-3% BSA or 5% non-fat milk in PBS

    • Block for 1-2 hours at room temperature

  • Sample preparation:

    • Prepare a dilution series for standard curve using the provided recombinant MET1A protein

    • Dilute samples appropriately in blocking buffer

  • Antibody dilution:

    • Titrate antibody concentrations (typically starting at 1:1000)

    • Incubate for 1-2 hours at room temperature

  • Detection optimization:

    • Use appropriate enzyme-conjugated secondary antibody

    • Optimize substrate incubation time (usually 15-30 minutes)

    • Read at appropriate wavelength

  • Troubleshooting:

    • High background: Increase blocking time or use different blocking agent

    • Low signal: Increase antibody concentration or sample loading

    • Non-specific binding: Include 0.05% Tween-20 in wash buffers

What controls should I include when working with MET1A antibody?

Including appropriate controls is critical for validating results with MET1A antibody:

Essential controls:

  • Positive control: Use the recombinant immunogen protein provided with the antibody package

  • Negative control: Include pre-immune serum to identify non-specific binding

  • No primary antibody control: Include samples where only secondary antibody is applied

  • Knockdown/knockout validation: Where possible, include samples from MET1A-deficient plants

  • Competing peptide control: Pre-incubate antibody with excess recombinant MET1A protein to confirm specificity

Analysis controls:

  • Loading control: Use antibodies against housekeeping proteins (e.g., actin, tubulin) to normalize protein loading

  • Tissue-specific controls: Include tissues known to have high and low MET1A expression

  • Cross-reactivity controls: Test the antibody against related methyltransferases to assess specificity

How can MET1A antibody be used to study protein-protein interactions?

MET1A likely forms complexes with other proteins involved in DNA methylation and chromatin remodeling. To study these interactions:

  • Co-immunoprecipitation (Co-IP):

    • Lyse plant cells in non-denaturing buffer

    • Incubate lysate with MET1A antibody

    • Capture antibody-protein complexes with Protein A/G beads

    • Analyze co-precipitated proteins by Western blot or mass spectrometry

This approach can be informed by studies of other methyltransferases. For example, studies of MATα1 (a different methyltransferase) revealed interactions with mitochondrial proteins through co-IP followed by mass spectrometry analysis .

  • Proximity ligation assay (PLA):

    • Fix and permeabilize plant tissues

    • Incubate with MET1A antibody and antibody against candidate interacting protein

    • Use PLA probes and detection reagents to visualize interactions in situ

  • Bimolecular Fluorescence Complementation (BiFC):

    • Generate fusion constructs of MET1A and candidate interacting proteins with split fluorescent protein fragments

    • Co-express in plant cells

    • Analyze fluorescence complementation by microscopy

  • Pull-down assays with recombinant proteins:

    • Express recombinant MET1A with an affinity tag

    • Incubate with plant extracts

    • Capture complexes using affinity resin

    • Identify interacting partners by mass spectrometry

How do I interpret changes in MET1A protein levels in different experimental conditions?

Interpreting changes in MET1A protein levels requires careful analysis:

  • Quantification approach:

    • Use densitometry for Western blots with appropriate normalization to loading controls

    • For ELISA, generate standard curves using the recombinant protein provided

    • Calculate relative or absolute protein quantities

  • Biological context interpretation:

    • Compare MET1A levels across developmental stages or stress conditions

    • Correlate MET1A protein changes with changes in DNA methylation patterns

    • Consider post-translational modifications that might affect antibody recognition

  • Statistical analysis:

    • Apply appropriate statistical tests (t-test, ANOVA) to determine significance

    • Use multiple biological replicates (minimum n=3)

    • Calculate confidence intervals for quantitative measurements

  • Integration with other data:

    • Correlate protein levels with transcript levels

    • Analyze in context of global methylation changes

    • Consider functional consequences of MET1A changes

Taking lessons from studies of other methyltransferases like MATα1, consider that changes in methyltransferase levels can have downstream effects on multiple cellular processes. For instance, changes in MATα1 levels affect mitochondrial function and influence protein methylation patterns .

What are the challenges in studying MET1A localization in plant cells?

Studying MET1A localization presents several challenges:

  • Fixation and permeabilization:

    • Plant cell walls require specialized fixation protocols

    • Optimize fixation to preserve epitope accessibility while maintaining cellular structure

    • Test different fixatives (4% paraformaldehyde, ethanol:acetic acid)

  • Antibody penetration:

    • Plant cell walls can hinder antibody penetration

    • Use enzymatic digestion (cellulase, macerozyme) to facilitate access

    • Optimize incubation times and temperatures

  • Autofluorescence:

    • Plant tissues exhibit significant autofluorescence

    • Use appropriate filters and spectral unmixing

    • Consider alternative detection methods (DAB, alkaline phosphatase)

  • Nuclear localization visualization:

    • MET1A is expected to localize primarily to the nucleus

    • Use nuclear markers (DAPI) for co-localization

    • Consider confocal microscopy for improved resolution

Drawing parallels from studies of MATα1, which was found to localize to both the cytosol and mitochondria using immunogold electron microscopy , similar advanced techniques might be needed to accurately determine MET1A subcellular distribution.

How do I troubleshoot weak or absent signals when using MET1A antibody?

When faced with weak or absent signals:

ProblemPossible CausesSolutions
No signal in Western blotInsufficient proteinIncrease protein loading (40-60 μg)
Inefficient transferCheck transfer efficiency with stained markers
Degraded antibodyUse fresh aliquot, verify storage conditions
Inappropriate detection methodTry more sensitive detection reagents
Epitope denaturationTry native conditions or different lysis buffer
Weak signal in ELISALow antibody concentrationIncrease primary antibody concentration
Insufficient antigenIncrease coating concentration
Suboptimal blockingTest different blocking agents (BSA, milk)
Detection system issuesUse amplification systems (biotin-streptavidin)
No signal in immunofluorescenceFixation issuesTest different fixation methods
Insufficient permeabilizationOptimize detergent concentration and time
Low protein expressionUse signal amplification methods
Epitope maskingTry antigen retrieval methods

How do I address non-specific binding with MET1A antibody?

Non-specific binding can complicate data interpretation. Address this issue by:

  • Optimizing blocking conditions:

    • Test different blocking agents (BSA, normal serum, milk)

    • Increase blocking time or concentration

    • Add 0.1-0.3% Triton X-100 or Tween-20 to reduce hydrophobic interactions

  • Antibody dilution optimization:

    • Perform titration experiments to determine optimal concentration

    • Generally, higher dilutions reduce non-specific binding

  • Pre-absorption controls:

    • Pre-incubate antibody with recombinant MET1A protein

    • Compare results with and without pre-absorption

  • Alternative secondary antibodies:

    • Test different sources or formats of secondary antibodies

    • Consider highly cross-adsorbed secondary antibodies

  • Additional washes:

    • Increase number and duration of wash steps

    • Use higher salt concentration in wash buffers

  • Validation with pre-immune serum:

    • Compare staining patterns with the provided pre-immune serum

    • Non-specific binding should be similar between pre-immune and immune sera

How can I validate antibody specificity for MET1A when working with novel plant species?

When expanding MET1A research to new plant species:

  • Sequence homology analysis:

    • Compare MET1A sequence between reference species (rice) and target species

    • Focus on the immunogen region used to generate the antibody

    • Predict cross-reactivity based on epitope conservation

  • Western blot validation:

    • Run samples from both species side by side

    • Verify expected molecular weight differences

    • Look for single, specific band at predicted size

  • Immunoprecipitation-mass spectrometry:

    • Perform IP with MET1A antibody using extracts from the new species

    • Identify precipitated proteins by mass spectrometry

    • Confirm MET1A identity through peptide matching

  • Genetic approach validation:

    • If available, use MET1A mutants or knockdown lines

    • Compare antibody signal between wild-type and mutant samples

    • Expect reduced or absent signal in mutants

  • Competing peptide approach:

    • Pre-incubate antibody with synthesized peptides from the new species' MET1A

    • Demonstrate signal reduction with specific peptide

How does MET1A function compare to related methyltransferases in different species?

Understanding MET1A in the context of other methyltransferases provides valuable research insights:

  • Functional comparison with mammalian DNA methyltransferases:

    • Unlike DNMT1 in mammals, plant MET1A may have broader substrate specificity

    • Both maintain CpG methylation but may differ in regulatory mechanisms

    • MET1A lacks the RFTS domain found in mammalian DNMT1

  • Comparison with other plant methyltransferases:

    • MET1A works alongside other methyltransferases (CMT3, DRM2) in plants

    • Different methyltransferase families maintain distinct methylation contexts (CpG, CHG, CHH)

    • Coordination between these enzymes ensures proper epigenetic regulation

  • Evolutionary conservation analysis:

    • MET1A structure is conserved across plant species but with species-specific adaptations

    • Functional domains show different levels of conservation

    • Catalytic domains typically show highest conservation

Interesting parallels can be drawn to studies of MATα1, which showed that this methyltransferase has multiple cellular functions beyond its canonical role, including protein-protein interactions that affect mitochondrial function .

How can I use MET1A antibody to study changes in methylation patterns during plant development?

To study developmental methylation changes:

  • Developmental time course experiments:

    • Collect tissues at different developmental stages

    • Quantify MET1A protein levels by Western blot or ELISA

    • Correlate with global DNA methylation measurements

  • Tissue-specific analysis:

    • Compare MET1A levels across different plant tissues

    • Use immunohistochemistry to visualize tissue-specific distribution

    • Correlate with tissue-specific methylation patterns

  • Stress response studies:

    • Expose plants to various stressors

    • Monitor changes in MET1A protein levels and localization

    • Connect to methylation changes at specific loci

  • Integration with genomic approaches:

    • Combine ChIP using MET1A antibody with sequencing (ChIP-seq)

    • Identify genomic regions bound by MET1A

    • Correlate with whole-genome bisulfite sequencing data

Similar to how MATα1 deficiency affects cellular functions through altered methylation patterns , changes in MET1A levels likely influence plant development through epigenetic regulation of key genes.

What emerging techniques might enhance MET1A antibody applications in plant epigenetics research?

Emerging techniques offer new possibilities for MET1A research:

  • Super-resolution microscopy:

    • Techniques like STORM, PALM, or SIM provide nanoscale resolution

    • Enable visualization of MET1A distribution within nuclear subdomains

    • Allow co-localization studies with chromatin marks at unprecedented resolution

  • Antibody engineering approaches:

    • Development of recombinant antibody fragments for improved tissue penetration

    • Single-domain antibodies with enhanced specificity

    • Biparatopic antibody designs that recognize multiple epitopes on MET1A

  • Proximity-dependent labeling:

    • Fusion of MET1A antibody with enzymes like BioID or APEX2

    • Identification of proteins in close proximity to MET1A in vivo

    • Mapping of the MET1A interactome in different cellular contexts

  • CRISPR-based techniques:

    • CRISPR-tagged endogenous MET1A for live imaging

    • CUT&RUN or CUT&Tag approaches using MET1A antibody

    • Combination with epigenetic editing to study causal relationships

Drawing from advances in other fields, techniques like those used to study MET trafficking (such as the biparatopic antibody approach ) could potentially be adapted for studying MET1A dynamics and interactions.

How might post-translational modifications affect MET1A antibody recognition?

Post-translational modifications (PTMs) can significantly impact antibody recognition:

  • Common PTMs affecting antibody binding:

    • Phosphorylation of serine, threonine, or tyrosine residues

    • Methylation of lysine or arginine residues

    • Acetylation of lysine residues

    • Ubiquitination or SUMOylation

  • Effects on epitope recognition:

    • PTMs may block antibody access to epitopes

    • Conformational changes induced by PTMs can expose or hide epitopes

    • Some antibodies specifically recognize modified forms

  • Strategies to address PTM interference:

    • Use phosphatase treatment to remove phosphorylation

    • Generate modification-specific antibodies for comprehensive analysis

    • Compare results from multiple antibodies targeting different epitopes

  • Analytical approaches:

    • Mass spectrometry to identify PTMs on MET1A

    • 2D gel electrophoresis to separate differently modified forms

    • Phos-tag gels to separate phosphorylated forms

Studies of other methyltransferases like MATα1 have shown that post-translational modifications can regulate their activity and interactions , suggesting similar regulatory mechanisms might exist for MET1A.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.